PICO question
In horses with liver disease, does histological evaluation of biopsies provide better prognostic information than results of blood tests?
P: Patient
Horses with liver disease.
I: Intervention/indicator
Histology of biopsies.
C: Comparison intervention/control
Blood tests.
O: Outcome
Accuracy in providing prognosis.
Search method
A PubMed search was performed using the terms: (equine or horse) AND (liver or hepatic) AND (prognosis OR outcome). The results were screened to identify studies which were relevant to the PICO question.
Exclusions
Papers older than 25 years, papers that did not relate to the PICO question (e.g. diagnosis of liver disease without investigation of prognosis); secondary sources of information (book chapters/review articles).
Studies included
One retrospective cohort study (Dunkel et al. 2015) compared serum bile acid (SBA) concentrations and a modified histopathological biopsy score for prediction of prognosis; one retrospective study (Durham et al. 2003a ) assessed the utility of serum biochemical and haematological data in determining prognosis; one retrospective study (Durham et al. 2003b ) developed a histopathological biopsy score and applied it retrospectively to horses with suspected liver disease to assess prognosis. Two retrospective case series (West 1996 and McGorum et al. 1999 ) compared concentrations of serum biochemical and haematological results between survivors and non-survivors. Dunkel et al. 2015 A retrospective study compared serum bile acid (SBA) concentrations with histological score for prediction of short-term (survival to discharge) and long-term (survival greater than 6 months) prognosis in 81 horses with biopsy confirmed hepatic disease. In addition to the biopsy score developed by Durham et al. (2003b; see below) , this study attempted to determine whether specific histological changes that contribute to the biopsy score were related to prognosis. Overall, 90% of horses survived short term and 83% survived longer than 6 months. In comparison to horses that survived, those that did not survive had significantly higher SBA, globulin, fibrinogen and total bilirubin concentrations and lower lactate dehydrogenase and albumin concentrations. Sensitivity and specificity of SBA and biopsy scores are reported in Table 1 . As well as overall biopsy score, the presence of several pathological changes relating to both reversible (for example inflammation) and irreversible pathology (such as portal and bridging fibrosis) were associated with a poorer prognosis.
Summary of evidence
Relevance to PICO question This is the only study that has directly compared blood values with histological evaluation of biopsy specimens. The authors concluded that histological score had a better specificity compared with SBA concentration.
Durham et al. 2003a
A retrospective study compared various serum biochemical and haematological data between survivors and nonsurvivors in 116 horses with liver disease. Serum biochemical and haematological results were categorised for statistical evaluation. Table 2 summarises the key differences between survivors and non-survivors.
Although biopsy score was not specifically compared with clinicopathological findings, a multivariable model including biopsy score identified a significantly increased risk of nonsurvival in horses with higher scores, in particular those with scores greater than 7/14.
Relevance to PICO question
This study provides evidence that there is a significant difference between survivors and non-survivors for some haematological and biochemical parameters.
Durham et al. 2003b
A biopsy grading system was devised which included the presence or absence, as well as the severity of fibrosis, reversible and irreversible cytopathology, inflammation, haemosiderosis and bile duct proliferation. The grading system was retrospectively applied to 73 horses with a suspected hepatopathy and 12 normal horses, and a weighted score (0-14) was then developed based on survival at 6 months. Comparison with other possible predictors of survival was not performed. Horses with total biopsy scores between 2 and 6 were 12 times less likely to survive to 6 months than horses with biopsy scores of 0 (hazard ratio 12.04; 95% CI 1.34-107.81; P=0.026), and those with biopsy scores between 7 and 14 were 46 times less likely to survive (HR 46.01; 95% CI 5.92-357.45; P<0.001).
Relevance to PICO question
This study provides evidence that by quantifying the severity of histological changes, a biopsy score can be utilised for prognostic purposes. The study population is likely to be relevant to modern equine practice in the UK, and the survival rate (in contrast to the two studies below) would also be consistent with cases currently seen in referral practice. Although blood results for this population were reported in the previous study, direct comparison of the utility of biopsy score vs. blood results is not possible with the information provided.
McGorum et al. 1999
A retrospective case series reported clinicopathological findings in 50 horses with hepatic disease, comparing values between survivors and non-survivors. A biopsy was obtained from 17/50 but histological findings were not reported nor was outcome in these cases. In contrast with the previously reported studies, a higher mortality rate of 72% (36/50) was reported, with half the cases diagnosed with pyrrolizidine alkaloid toxicity. Significant differences between survivors and non-survivors were identified for: GGT, GLDH and SBA (Table 3 ).
Relevance to PICO question
As biopsy results were not reported, comparison of their utility vs. blood results cannot be made. The types of liver disease and the high mortality rate would not be typical of most hepatic disease cases seen in equine practice today. Higher levels of hepatic/biliary enzyme activity and SBA were associated with a poorer prognosis.
West 1996
A retrospective case series reported clinical and pathological findings in 40 horses with hepatic disease. The horses were classified into those with hepatic necrosis (n = 18); hepatic lipidosis (n = 8); pyrrolizidine alkaloid toxicity (n = 9) and metastatic neoplasia of the liver (n = 5). Admission and serial (every 2-3 days) changes in blood biochemistry were reported, and compared with the mean values of normal horses. Comparisons between survivors and non-survivors were not directly made, although the authors commented that in the hepatic necrosis group the values of SBA, GGT and glutamate dehydrogenase (GD) 'declined to normal on clinical recovery, whereas in the animals that subsequently died values remained high'. Survival rates for other groups were not sufficiently high to make comparisons.
Relevance to PICO question
As biopsy results were not reported, comparison of their utility vs. blood results cannot be made. The types of liver disease and the high mortality rate would not be typical of most hepatic disease cases seen in equine practice today.
Clinical implications
Although the level of evidence is not high, and all studies had obvious weaknesses, the populations studies in the more recent publications are likely to be relevant to both first opinion and referral equine practice in the UK. Based on the available evidence, histological evaluation of hepatic biopsies provides better prognostic information than does the results of blood tests. Of the routinely performed blood tests, SBA concentration provides the best prognostic information. 
